New malware variant targets IoT devices – Technologist

A new variant of the InterPlanetary Storm malware is targeting IoT devices, such as TVs that run on Android operating systems, and Linux-based machines, such as routers with ill-configured SSH service, according to Barracuda Networks researchers. The new variant gains access to machines by running a dictionary attack against SSH servers, similar to FritzFrog, another … Read more

Best SEO Agencies in New York City 2024 – Technologist

Customers are actively searching online for products or services. Therefore, having a website is crucial because it provides useful information about your business or company to your target audience. With countless websites available, appearing in a prominent position is essential on search engine result pages for user queries. This is where the significance of search … Read more

Only 20% of industrial firms prioritise IoT-related incidents – Technologist

The digitalisation of industrial infrastructure is underway and 55% of organisations are confident that the Internet of Things (IoT, as one of its key aspects, will change the state of security in industrial control systems (ICS), according to Kaspersky’s recent report. Entitled “The State of Industrial Cybersecurity in the Era of Digitalization”,  the report however … Read more

The Washington Post interviewed Andy Levy regarding winning reversal of BGL client, Sophia Negroponte’s murder conviction before the Appellate Court of Maryland. – Technologist

As reported by the Washington Post, partner Andy Levy and attorney Lauren Kelleher won a reversal of client Sophia Negroponte’s murder conviction in a Maryland appeals court. The Appellate Court of Maryland threw out Ms. Negroponte’s conviction and 35-year sentence and remanded the case to Montgomery County for a new trial. In its opinion the … Read more

Zacks Small Cap Research – EDSA: Development of EB05 in ARDS Continues… – Technologist

By David Bautz, PhD NASDAQ:EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Update on EB05 Development in ARDS Edesa Biotech, Inc. (NASDAQ:EDSA) is developing EB05 (paridiprubart) as a treatment for acute respiratory distress syndrome (ARDS). The drug is currently being evaluated in a Phase 3 clinical trial of approximately 600 patients hospitalized with ARDS … Read more